Government regulations

President Donald Trump holds up a copy of the New York Post as he speaks before signing an executive order aimed at curbing protections for social media giants, in the Oval Office of the White House, Thursday, May 28, 2020, in Washington. (AP Photo/Evan Vucci)
Associated Press
May 28, 2020 - 5:15 pm
WASHINGTON (AP) — President Donald Trump escalated his war on Twitter and other social media companies Thursday, signing an executive order challenging the lawsuit protections that have served as a bedrock for unfettered speech on the internet. Announced with fanfare, the president's action yet...
Read More
House Speaker Nancy Pelosi of Calif., speaks with reporters alongside Senate Minority Leader Sen. Chuck Schumer of N.Y. after the Senate approved a nearly $500 billion coronavirus aid bill, Tuesday, April 21, 2020, on Capitol Hill in Washington. (AP Photo/Patrick Semansky)
Associated Press
April 21, 2020 - 5:49 pm
WASHINGTON (AP) — A $483 billion coronavirus aid package flew through the Senate on Tuesday after Congress and the White House reached a deal to replenish a small-business payroll fund and provided new money for hospitals and testing. Passage was swift and unanimous, despite opposition from...
Read More
FILE - This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2. Also known as 2019-nCoV, the virus causes COVID-19. The sample was isolated from a patient in the U.S. On Tuesday, April 21, 2020, U.S. health regulators OK'd the first coronavirus test that allows people to collect their own sample at home, a new approach that could help expand testing options in most states. The sample will still have to be shipped for processing back to LabCorp, which operates diagnostic labs throughout the U.S. (NIAID-RML via AP)
Associated Press
April 21, 2020 - 12:08 pm
WASHINGTON (AP) — U.S. health regulators on Tuesday OK'd the first coronavirus test that allows people to collect their own sample at home, a new approach that could help expand testing options in most states. The test from LabCorp will initially only be available to health care workers and first...
Read More
In this Thursday, April 16, 2020, photo, wearing a protective mask and gloves, budtenders prepare orders for customers to pick-up at The Higher Path cannabis dispensary in the Sherman Oaks section of Los Angeles. Monday is April 20, or 4/20. That’s the code for marijuana’s high holiday, which is usually marked with outdoor festivals and communal smoking sessions. But this year, stay-at-home orders have moved the party online as the marijuana market braces for an economic blow from the coronavirus crisis. (AP Photo/Richard Vogel)
Associated Press
April 20, 2020 - 12:49 am
LOS ANGELES (AP) — The unofficial holiday celebrating all things cannabis arrives Monday as the nation’s emerging legal marijuana market braces for an economic blow from the coronavirus crisis, with many consumers reducing spending or going underground for deals. It was supposed to be a long...
Read More
Treasury Secretary Steven Mnuchin and President Donald Trump listen to a question during a conference call with banks on efforts to help small businesses during the coronavirus pandemic, at the White House, Tuesday, April 7, 2020, in Washington. (AP Photo/Evan Vucci)
Associated Press
April 08, 2020 - 6:57 pm
WASHINGTON (AP) — Congress is rushing headlong into a conflict over the next coronavirus aid package as the White House wants to pump $250 billion into a small business fund but opposes Democrats' proposal to tack on billions for protective gear, food stamps and support to state and local...
Read More
Treasury Secretary Steven Mnuchin and Senate Majority Leader Mitch McConnell, R-Ky., listen as President Donald Trump speaks before he signs the coronavirus stimulus relief package in the Oval Office at the White House, Friday, March 27, 2020, in Washington. (AP Photo/Evan Vucci)
Associated Press
March 31, 2020 - 6:55 pm
WASHINGTON (AP) — President Donald Trump's impeachment trial distracted the federal government from the coronavirus as it reached the United States in January, Senate Majority Leader Mitch McConnell said Tuesday, despite warnings at the time from public health experts and members of Congress about...
Read More
People wait in a line to enter a gun store in Culver City, Calif., March 15, 2020. (AP Photo/Ringo H.W. Chiu)
Associated Press
March 27, 2020 - 2:53 pm
In some parts of the U.S., authorities say gun shops aren't essential businesses and should close during stay-at-home orders meant to slow the coronavirus. In other places, officials are stopping background checks for concealed carry permits. Elsewhere, city leaders have invoked emergency powers...
Read More
President Donald Trump speaks about the coronavirus in the James Brady Briefing Room, Wednesday, March 25, 2020, in Washington as Vice President Mike Pence and Treasury Secretary Steven Mnuchin listen. (AP Photo/Alex Brandon)
Associated Press
March 26, 2020 - 9:28 pm
WASHINGTON (AP) — The contrast could hardly be more stark. Gov. Andrew Cuomo of New York has said that if all of his sweeping, expensive measures to stem the coronavirus saved one life, it would be worth it. President Donald Trump has another view: The costs of shutting down the economy outweigh...
Read More
Senate Majority Leader Mitch McConnell of Ky. gives a thumbs up as he arrives on Capitol Hill, Wednesday, March 25, 2020, in Washington. (AP Photo/Andrew Harnik)
Associated Press
March 26, 2020 - 5:07 am
WASHINGTON (AP) — The Senate passed an unparalleled $2.2 trillion economic rescue package steering aid to businesses, workers and health care systems engulfed by the coronavirus pandemic. The unanimous vote Wednesday came despite misgivings on both sides about whether it goes too far or not far...
Read More
FILE - In this July 9, 2015, file photo, a man walks outside the headquarters of Gilead Sciences in Foster City, Calif. Gilead Sciences said Wednesday, March 25, 2020 it will give up the specialty status it received days earlier for its COVID-19 drug amid public outrage that the company was seeking to boost the profits of its treatment. (AP Photo/Eric Risberg, File)
Associated Press
March 25, 2020 - 2:55 pm
WASHINGTON (AP) — Facing public criticism, the maker of a promising coronavirus drug said Wednesday it will waive a special regulatory designation that could have allowed it to block competition and boost profits for its treatment. Gilead Sciences said it will ask U.S. regulators to revoke the so-...
Read More

Pages